Evidence map›Paper›PMID 34030589›Full record

ArticleAutophagy2021

Transcription- and phosphorylation-dependent control of a functional interplay between XBP1s and PINK1 governs mitophagy and potentially impacts Parkinson disease pathophysiology.

Wejdane El Manaa, Eric Duplan, Thomas Goiran, Inger Lauritzen, Loan Vaillant Beuchot, Sandra Lacas-Gervais, Vanessa Alexandra Morais, Han You, Ling Qi, Mario Salazar and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Roles of mitophagy and immune infiltration in Parkinson's disease: new perspectives from bioinformatics analysis and A53T transgenic mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. PTEN: a new dawn in Parkinson's disease treatment.Frontiers in cellular neuroscience · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Wejdane El ManaaINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.
Eric DuplanINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.
Thomas GoiranINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.
Inger LauritzenINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.
Loan Vaillant BeuchotINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.
Sandra Lacas-GervaisCentre Commun de Microscopie Appliquée, Université Côte d'Azur, Nice, France.
Vanessa Alexandra MoraisInstituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Han YouState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
Ling QiDivision of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, NY, USA.ORCID 0000-0001-8229-0184
Mario SalazarDivision of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Umut OzcanDivision of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Mounia ChamiINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.ORCID 0000-0003-1498-7187
Frédéric CheclerINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.
Cristine Alves da CostaINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Sophia-Antipolis, Université Côte d'Azur, Valbonne, France.
Centre National de la Recherche Scientifique · FRBoston Children's Hospital · USUniversité Côte d'Azur · FRUniversity of Lisbon · PTUniversity of Michigan · USXiamen University · CN

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
NIDDK NIH HHS P30 DK020572
6 · The paper itself

Abstract

Parkinson disease (PD)-affected brains show consistent endoplasmic reticulum (ER) stress and mitophagic dysfunctions. The mechanisms underlying these perturbations and how they are directly linked remain a matter of questions. XBP1 is a transcription factor activated upon ER stress after unconventional splicing by the nuclease ERN1/IREα thereby yielding XBP1s, whereas PINK1 is a kinase considered as the sensor of mitochondrial physiology and a master gatekeeper of mitophagy process. We showed that XBP1s transactivates

Indexed as

MitophagyParkinson DiseaseAnimalsAutophagyEndoribonucleasesMicePhosphorylationProtein KinasesProtein Serine-Threonine KinasesPTEN-Induced Putative KinaseX-Box Binding Protein 1EndoribonucleasesProtein KinasesProtein Serine-Threonine KinasesPTEN-Induced Putative KinaseX-Box Binding Protein 1Xbp1 protein, mouseMitophagyParkinson diseasephosphorylationPINK1transcriptionunfolded protein responseXBP1

Identifiers

PMID34030589
PMCPMC8726674
OpenAlexW3165828647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.